Linked Life Data

15585610

Source:http://linkedlifedata.com/resource/pubmed/id/15585610

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
2004-12-8
pubmed:abstractText
A multicenter, randomized study was undertaken to estimate the single agent activity of Tositumomab and to determine the contribution of radioisotope-labeling with (131)I to activity and toxicity by comparing treatment outcomes for Tositumomab and Iodine I 131 Tositumomab (BEXXAR) to an equivalent total dose of unlabeled Tositumomab.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
7792-8
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15585610-Adult, pubmed-meshheading:15585610-Aged, pubmed-meshheading:15585610-Aged, 80 and over, pubmed-meshheading:15585610-Antibodies, Monoclonal, pubmed-meshheading:15585610-Antigens, CD20, pubmed-meshheading:15585610-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15585610-Disease-Free Survival, pubmed-meshheading:15585610-Drug Resistance, Neoplasm, pubmed-meshheading:15585610-Female, pubmed-meshheading:15585610-Humans, pubmed-meshheading:15585610-Iodine Radioisotopes, pubmed-meshheading:15585610-Lymphoma, B-Cell, pubmed-meshheading:15585610-Lymphoma, Non-Hodgkin, pubmed-meshheading:15585610-Male, pubmed-meshheading:15585610-Middle Aged, pubmed-meshheading:15585610-Neoplasm Recurrence, Local, pubmed-meshheading:15585610-Radioimmunotherapy, pubmed-meshheading:15585610-Remission Induction
pubmed:year
2004
pubmed:articleTitle
The radioisotope contributes significantly to the activity of radioimmunotherapy.
pubmed:affiliation
Stanford University, Stanford, California, USA. davisth@mail.nih.gov
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study